CDK1 and cancer: In this study, we reveal the cyclin-dependent kinase 1 (CDK1) and peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) as two previously uncharacterized regulators of pVHL stability in multiple cancer types harboring wild-type VHL including TNBC.